Skip to main content
. 2014 Sep 6;289(42):29437–29445. doi: 10.1074/jbc.M114.595165

TABLE 2.

Chemical name and calculated KS for substrate/inhibitor to active site of bsNOS, bsNOS in the presence of a 10 molar excess YkuN and bBiDomain

Error represents the error associated with the fit curve used to calculate the KS. Values not determined (n.d.) are indicated.

Compound Chemical name bsNOS bsNOS + 10x YkuN bBiDomain
KS, μm KS, μm KS, μm
l-Arg (S)-2-Amino-5-guanidinopentanoic acid 0.8 ± 0.1 (8) 6.5 ± 0.2 16 ± 2
NOHA N-Omega-hydroxy-l-arginine 3.2 ± 0.5 2.2 ± 0.1 13 ± 5
l-NNA N-Omega-nitro-l-arginine 1.3 ± 0.1 (8) 4.9 ± 0.9 24 ± 7
l-NAME N-Omega-nitro-l-arginine methyl ester 66 ± 46 n.d. n.d.
ITU Ethylisothiourea 9.3 ± 1.2 n.d. n.d.
7-NI 7-Nitroindazole 3.5 ± 0.4 6.8 ± 0.8 27 ± 4
7-NI-Br 3-Bromo-7-nitroindazole 12 ± 1 n.d. n.d.
1 6-({[(3R,5S)-5-{[(6-Amino-4-methylpyridin-2-yl)methoxy]methyl}pyrrolidin-3-yl]oxy}methyl)-4-methylpyridin-2-amine 4.4 ± 0.1 (8) n.d. n.d.
2 6,6′-{[(2S,3S)-2-Aminobutane-1,3-diyl]bis(oxymethanediyl)}bis(4-methylpyridin-2-amine) 1.1 ± 0.1 (8) n.d. n.d.